Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program
about
Meta-analysis in genome-wide association studiesThe complex interplay of genetic and lifestyle risk factors in type 2 diabetes: an overviewIslet biology, the CDKN2A/B locus and type 2 diabetes risk.Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention ProgramIndividualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.Interaction of iron status with single nucleotide polymorphisms on incidence of type 2 diabetes.The influence of rare genetic variation in SLC30A8 on diabetes incidence and β-cell function.Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort studyInvited commentary: Gene X lifestyle interactions and complex disease traits--inferring cause and effect from observational data, sine qua non.Improvements in glucose homeostasis in response to regular exercise are influenced by the PPARG Pro12Ala variant: results from the HERITAGE Family StudyEvaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study.IGF2BP2 and obesity interaction analysis for type 2 diabetes mellitus in Chinese Han population.Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention ProgramEffects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.Impact of positive family history and genetic risk variants on the incidence of diabetes: the Finnish Diabetes Prevention Study.Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant.The emerging genetic architecture of type 2 diabetesUpdated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program.Genetic variants associated with optic nerve vertical cup-to-disc ratio are risk factors for primary open angle glaucoma in a US Caucasian population.Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphismAssociation analysis of 31 common polymorphisms with type 2 diabetes and its related traits in Indian sib pairs.Genetic risk assessment of type 2 diabetes-associated polymorphisms in African AmericansIGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes.Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention programPersonalized medicine in diabetes mellitus: current opportunities and future prospectsHigh-fat-diet induced development of increased fasting glucose levels and impaired response to intraperitoneal glucose challenge in the collaborative cross mouse genetic reference population.Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trialUse of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review.Type 2 Diabetes Genetics: Beyond GWAS.Evaluation of genome-wide association study-identified type 2 diabetes loci in African Americans.Insulin resistance in women's health: why it matters and how to identify itGene-environment and gene-treatment interactions in type 2 diabetes: progress, pitfalls, and prospectsPregnancy augments hepatic glucose storage in response to a mixed meal.The rs11705701 G>A polymorphism of IGF2BP2 is associated with IGF2BP2 mRNA and protein levels in the visceral adipose tissue - a link to type 2 diabetes susceptibility.Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: a study of 16,003 Swedish adults.Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men.Personalized pharmacotherapy for Type 2 diabetes mellitus.The pharmacogenetics of type 2 diabetes: a systematic review.IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.
P2860
Q24273398-619A6F5D-FD33-436B-BD83-638681BE4FDBQ26997813-1A416127-B672-4F50-9F5B-1313EF0471C8Q30251397-8BB6EB5D-E15B-44E2-92B5-8F097B59901AQ30524978-A7806543-B7B7-453B-A1CC-CD8BA454D265Q30571118-A5535592-1E98-47BA-9B61-CEF19B590A1DQ33562929-4FDB5667-79EE-4039-BD98-ECED99E568B0Q33568942-82C34CB9-4F0D-46CC-B42C-606D6B326BA5Q33638105-F189EF37-D82A-4209-9F10-521013548284Q33694207-B1264945-2352-4DEF-AE7B-72AA47D2EFD2Q33735643-0D22EE93-2FCC-4975-95B4-9C26E8C32CD6Q33891576-944F0A23-C6F4-4BD1-9FBB-B87A45804450Q33998893-BF9ED0C2-5ED1-4F97-962E-4CEB30D11E41Q34404405-0D33FB49-61E5-473F-A423-40B20C90BF4DQ34415887-ADC08CF0-B9B2-461E-A4B1-44400B42F74BQ34507211-21DBFA09-10FA-4F3A-A332-E738E2CE8C43Q34527242-16AF52B2-0958-4D94-96BB-314A3EFA74E8Q34712198-74ECA8CF-986F-410B-8287-7BC41F505DAFQ34718943-359280B0-3863-4804-BF56-268A15687A32Q35005896-9ECA9232-8B01-4D9C-B3EC-6B999DF9AAE0Q35039274-A12E6F85-5CD1-43C2-938B-DA27813C7D0EQ35493159-50435567-A37A-48B2-B97D-4AE3E5AB43C9Q35633247-3997D6E3-8ADC-4AA5-9C9E-6A44A19A20C5Q35688254-47E4F7E4-CBC2-409A-9BD4-96958C1481BFQ35708056-EDCA8044-40BA-43E3-ACEA-A0165FC439DCQ35757076-C2F4ECA1-294F-4167-81EF-296F98DF5368Q35779453-A53D5ABF-DEBF-4AE0-8EEA-B879C34696B8Q35884458-7E6E827A-D0E7-43C0-892A-A0BAD7AB7247Q36120556-3D6EBD6E-3728-4D17-8CD5-F3AD55163079Q36384522-8506064E-1E30-41EB-8928-B50CF6687024Q36464788-D1BBB581-05D8-4A66-9294-48A81CFA812BQ36606638-047A3803-EFBE-4CE2-896B-5A0E6D26679CQ36664199-2BFAFD2A-6C69-45AC-89E1-570F5DC20E46Q36782845-34CC3070-05A7-48A1-A54E-E6518C194CEEQ36825071-C4835004-F970-413B-A0DB-BE1820730909Q36978036-29693F94-32E9-4FEC-934E-1A702A8A3160Q37193742-657A2886-A179-4479-8977-5EFEC04267BAQ37317415-09A97277-2131-430D-B33D-73756AC2A514Q37365702-4B61B5F6-3AC4-4E8D-AC96-70E311B8FEDBQ37597017-BB4FCAB0-3B81-44D5-B5E0-6CC00CF721BBQ37729214-27F19ECD-01E1-433B-942A-836F84F4059A
P2860
Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Extension of type 2 diabetes g ...... he diabetes prevention program
@en
type
label
Extension of type 2 diabetes g ...... he diabetes prevention program
@en
prefLabel
Extension of type 2 diabetes g ...... he diabetes prevention program
@en
P2093
P2860
P50
P356
P1433
P1476
Extension of type 2 diabetes g ...... he diabetes prevention program
@en
P2093
Allan F Moore
Jarred B McAteer
Jose C Florez
Kathleen A Jablonski
Paul W Franks
Toni I Pollin
P2860
P304
P356
10.2337/DB08-0284
P407
P50
P577
2008-06-10T00:00:00Z